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Introduction: The growth potential of the tumor-like Echinococcus multilocularis
metacestode (causing alveolar echinococcosis, AE) is directly linked to the nature/
function of the periparasitic host immune-mediated processes. Previous studies
had shown that regulatory T cells (Tregs) become gradually up-regulated in the
course of both chronic human and murine AE. Thus we now tackled the role of
FoxP3þTregs and FoxP3þ-Treg-regulated immune response in contributing to the
control of this helminthic infection.
Methods: The infection outcome in E. multilocularis-infected DEREG mice was
measured upon determining parasite load (wet weight of parasitic metacestode
tissue). Flow cytometry and qRT-PCR were used to assess Treg, Th17-, Th1-,
Th2-type immune responses and antigen presenting cell activation.
Results: We showed that E. multilocularis-infected DEREG-mice treated with DT
(as compared to infected control DEREG-mice without DT application) exhibited
a significantly lower parasite load, associated with a persisting capacity of
co-stimulation, and an increased Th1/Th17-polarization.
Conclusions: FoxP3þ Tregs appear as one of the key players in immune regulatory
processes favoring (i) metacestode survival by inhibiting the maturation potential
of co-stimulatory activity and (ii) T cell exhaustion (suppressing Th1/Th17-type
immune responses). We showed as well that prospectively, targeting FoxP3þ Tregs
could be an option to develop an immunotherapy against AE.
Introduction
Alveolar echinococcosis (AE) is a very severe zoonotic
helminthic disease, which is fatal if patients are not
appropriately diagnosed and subsequently treated [1]. AE
is characterized by a chronically progressing hepatic
damage caused by the continuous proliferation of the
larval stage (metacestode) of Echinococcus multilocula-
ris [2], that behaves like a slowly growing and metastasiz-
ing liver cancer, thus progressively also invading other host
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tissues and organs such as lungs and brain, among
others [3]. There is growing evidence that the composition
and type of the—especially periparasitic—immune
response elicited by E. multilocularis-infection causatively
influences the outcome and progression of disease [2, 3],
ranging from resistance (self-cure) to a rapidly evolving
fatality for the patient (high susceptibility) [4]. In humans,
a T helper cell (Th)2-oriented immunity is associated with
increased susceptibility to disease leading to chronic AE,
while Th1 cell-activation has been linked to reduced or
abrogated metacestode proliferation, or even protection,
which occurs when the parasite becomes aborted, that is,
resulting in the formation of ‘‘died-out’’ lesions [2, 3].
Experimental murine AE is immunologically characterized
by an initial Th1-oriented response during the early stage
of infection (till 1 month post-infection (p.i.)) that
gradually switches to a more dominant Th2-orientation
during the chronic phase of AE (2–4 months p.i.). This still
mostly mixed Th1/Th2 profile associates with the expres-
sion of pro-inflammatory cytokines in the peri-parasitic
granuloma, and partial/relative protective immunity
(restricted parasite growth) occurs through fibrosis and
necrosis by potentially inflicting a starving process to the
parasite [4]. It has been previously reported that
CD4þCD25þ T regulatory cells (Tregs) appeared quanti-
tatively up-regulated in human AE, and it was claimed that
this up-regulation associated to the blunting of immune
responses to specific antigens, and/or to the suppression of
the secretion of pro-inflammatory cytokines, especially
through high interleukin (IL)-10 and transforming growth
factor beta1 (TGF-b1) production [5]. In the experimental
mouse model, increased CD4þCD25þ Tregs were also
observed within the peritoneal cell population, a result that
concurred with other findings demonstrating that
E. multilocularis antigens promote T cell differentiation
into Treg cells [6].
So far, only few studies have reported on the possible
involvement of Tregs in the immune regulation of murine
AE [4, 7, 8], none with regard to the possible mechanism of
FoxP3-regulation. The major aims of the present study were:
(i) to address the role of FoxP3þ Tregs in T cell reactivity as
well as its effect on co-stimulation at the early (1 month p.i.)
and at a late chronic (4 months p.i.) stage of E. multilocularis
infection, employing a mouse model that allows to induce
the depletion of regulatory T cells (DEREG); (ii) to explore
whether FoxP3þ Tregs could be envisaged as an immuno-
therapeutical candidate for supporting treatment against AE;
(iii) to provide a comprehensive picture of the possible
mechanism and pathways involved in immune regulation at
the early stage of E. multilocularis infection. To achieve these
goals, we investigated the co-stimulation status of CD11bþ
and CD11cþ APCs, together with Th1/Th2-related plus
Treg/Th17-related cytokine expression levels, at the early




prote ins induces Treg- re la ted nuc lear
transcriptional factor and cytokine up-regulation
FoxP3þ and IL-10þ frequency within CD4þ T cells was
significantly higher in peritoneal exudate cell PECs and
spleen cells of E. multilocularis infected (AE-WT) mice at
4 months post-infection (p.i.) when compared to non-
infected WT-controls (Fig. 1A–D). Overall, and with regard
to those two parameters, PECs seemed to bemore affected by
infection than spleen cells. To further explore the effect of
parasite metabolic E. multilocularis vesicle fluid (VF) on
Tregs, spleen cells from AE-WT mice and non-infected WT
controls were each co-cultured with three different concen-
trations of VF (2mg/mL, 10mg/mL, 50mg/mL, respectively),
and foxp3 gene-expression levels were subsequently deter-
mined by qRT-PCR. Findings indicated that foxp3 gene-
expression levels were up-regulated in response to high
concentration of VF (50mg/mL), when compared to non-
infected animals (Fig. 1E).
FoxP3 plays a critical role in the overall infection
control
To assess the putative role of FoxP3 in the control of parasite
growth/proliferation, E. multilocularis-infected DEREG mice
with/without DT application and corresponding control WT
littermates, respectively, were analyzed after 1 and 4 months
p.i. with regard to the recovered parasite mass. In a first
experiment (experimental step a), DT application (110 ng/
injection/mouse) was initiated one day prior to infection and
was maintained during 4 months (three times/week). We
found that AE-DEREG mice with DT application
(AE-DEREG DTþ) had a significantly lower parasite load
when compared to AE-DEREGmice without DT application
(AE-DEREG DT-) both at 1-month p.i. (0.14 0.02 vs.
0.27 0.03 g, p¼ 0.044) and 4 months p.i. (3.96 2.09 vs.
12.62 2.79 g, p¼ 0.005) (Fig. 1F). To study whether FoxP3
is involved in orientation of the immune response at the early
stage of infection only (experimental step b), we applied DT
(110 ng/mouse) as above but maintained DT application for
only 1 month, and then let the infection proceed for another
3 months in the absence of further DT application. The
parasite load was significantly lower in AE- DEREG DTþ
mice when compared to AE-DEREG DT- at 1-month p.i.
(0.15 0.01 vs. 0.26 0.04 g, p¼ 0.005) and still significantly
lower at 4 months p.i.. (5.50 0.57 vs. 12.14 3.23 g,
p¼ 0.027) (Fig. 1G). Respective flow cytometric analyses
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showed that FoxP3was strongly suppressed after 1monthDT
application, but less so after 3-months DT-application
(Supplementary Fig. S1A–D).
Co-stimulation of antigen presenting cells (APCs) is
less affected in DEREGDTþ than in DEREGDT-mice
at the early stage of infection (1 month p.i.)
The role of FoxP3 in the co-stimulation of CD11bþ and
CD11cþ APCs was measured, in both PECs and spleen cells
from AE-DEREG DTþ, AE-DEREG DT- mice, and their
non-infected controls, respectively. Among CD11bþ APCs,
the frequency of CD40 and MHCII was higher at 1-month
p.i. in spleen cells but not in PECs of AE-DEREGDTþ, when
compared to AE-DEREG DT- mice (Fig. 2A and B).
However, among CD11cþ APCs there was no difference in
the MHCII frequency between AE-DEREG DTþ mice and
AE-DEREG DT- mice (data not shown).
Subsequently, we assessed the same parameters but upon
in vitro cultivation and stimulation with ConA. Findings
revealed that CD40 frequency in CD11bþ APCs from
AE-DEREG DTþ at 1-month p.i. was significantly higher
Figure 1. FoxP3- and IL-10-levels affected by E. multilocularis infection, and association between FoxP3 and metabolites, parasite load development in
E. multilocularis-infected mice. (A) Frequency of FoxP3þ T cells within CD4þ T cells in PECs and spleen cells from AE-WT and Control-WTmice at 1 month
and 4 months post-infection. (B) Representative images of FoxP3þ T cells within CD4þ T cells in PECs from both AE-WT and Control-WTmice at 4 months
post-infection. (C) Frequency of IL-10þ T cellswithin CD4þ T cells in PECs and spleen cells fromAE-WTandControl-WTmice at 1month and 4months post-
infection. (D) Representative images of IL-10þ T cells within CD4þ T cells in PECs from both AE-WT and Control-WT mice at 4 months post-infection.
Comparison between groups was performed using a one-way ANOVA with Bonferroni's multiple comparison post-test for statistical analysis. p< 0.006
(E) foxp3 gene expression in spleen cells fromAE-WT andControl-WTmice, co-cultured with 2, 10, 50mg/mL E.multilocularivesicle ﬂuid (VF) (measured by
qRT-PCR). The same cell reactions performedwithout VFwere used as non-stimulated controls. p< 0.05. AU: arbitrary units. (F) Parasite load inAE-DEREG
DT- andAE-DEREGDTþmice assessed bywet weight measurement at 1month and 4months post- infection. DT applicationwith 110ng/injection/mouse
started 1 day before infection andwas maintained for 4 months (three times/week). (G) Parasite load in AE-DEREG DT- and AE-DEREG DTþmice assessed
bywetweightmeasurement at 1month and 4months post- infection. DT applicationwith 110ng/injection/mouse (three times/week) started 1 day before
infection and was maintained for 1 month. Data represent mean SD of three independent experiments of a total of 8–10 mice in each group (4–5 mice
per group in each independent experiment). Comparison between groups was performed using a one-way ANOVA for statistical analysis. p< 0.05.
“DEREG DT-,” foxp3 inducible knock-down mice (DEREG mice) without DT application; “DEREG DTþ,” DEREG mice with DT application; “AE- DEREG
DT-,” E. multilocularis-infected DEREGwithout DT application; “AE- DEREG DTþ,” E. multilocularis-infected DEREGmice with DT application. “Control,”
non-infected mice; “1m,” 1-month p.i.; “4m,” 4 months p.i. “PEC,” peritoneal exudate cells; “Spleen,” spleen cells.
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than in AE-DEREG DT- mice (Fig. 2C and D). MHCII
frequency yielded no difference in both subpopulations of
CD11bþ and CD11cþ APCs.
Co-stimulatory signals for T cell activation and
survival are less affected in DEREG DTþ than in
DEREG DT- mice at the early stage of infection
(1 month p.i.)
Anticipating a putative effect of FoxP3 on APCs for T cell
activation and survival during E. multilocularis infection, we
investigated co-stimulatory markers for T cell activation and
survival CD80 and CD86 in CD11bþ and CD11cþ APCs, in
both PECs and spleen cells from AE-DEREG DTþ, and
AE-DEREG DT- mice and respective non-infected controls.
Flow cytometry showed that, in both CD11bþ and CD11cþ
APCs, the frequency of the maturation marker CD86 in
PECs but not in spleen cells was higher in AE-DEREG DTþ
than in AE-DEREGDT-mice (Fig. 3A–D). However, in both
CD11bþ andCD11cþAPCs, there was no difference in CD80
frequency between AE-DEREG DTþ and AT-DEREG
DT- mice (Fig. 3A and C).
Subsequently, we assessed the same parameters but
upon in vitro cultivation and stimulation with ConA.
Findings revealed that CD86 frequency in both CD11bþ and
CD11cþ APCs from AE-DEREG DTþ at 1-month p.i. was
Figure 2. CD40 and MHCII expression levels in both CD11bþ APCs in both AE-DEREG DT- and AE-DEREG DTþmice at 1 month post-infection, and in
response to ConA. (A) Frequency of co-stimulationmarkers CD40 andMHCII within CD11bþAPCs in peritoneal and spleen cells fromAE-DEREGDT- and
AE-DEREGDTþmice 1month post infection. (B) Representative images of CD40þ cells within CD11bþAPCs in spleen cells from both AE-DEREGDT- and
AE-DEREG DTþ mice at 1 month post-infection, non-infected mice as Control mice. (C) Frequency of co-stimulation markers CD40 and MHCII within
CD11bþ APCs in spleen cells from AE-DEREG DT- and AE-DEREG DTþmice, co-cultured with 2mg/mL ConA. (D) Representative images of CD40þ cells
within CD11bþ APCs in spleen cells from both AE-DEREG DT- and AE-DEREG DTþmice at 1 month post-infection (non-infected mice as Control mice),
co-cultured with 2mg/mL ConA. The same cell reactions performed without ConA were used as non-stimulated controls. DT application with 110 ng/in
jection/mouse started 1 day before infection and was maintained for 4 months (three times/week). Data represent mean SD of three independent
experiments of a total of 8–10 mice in each group (4–5 mice per group in each independent experiment). Comparison between groups was performed
using a one-way ANOVA with Bonferroni's multiple comparison post-test for statistical analysis. p< 0.01. “DEREG DT-,” foxp3 inducible knock-down
mice (DEREGmice)without DT application; “DEREGDTþ,”DEREGmicewith DT application; “AE- DEREGDT-,” E.multilocularis-infectedDEREGwithout
DT application; “AE- DEREG DTþ,” E. multilocularis-infected DEREG mice with DT application. “Control,” non-infected mice; “1m,” 1-month p.i.;
“4m,” 4 months p.i.. “PEC,” peritoneal exudate cells; “Spleen,” spleen cells.
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significantly higher than in those from AE-DEREG
DT- mice, while CD80 frequency yielded no difference in
both CD11bþ and CD11cþ APCs (Fig. 4A–D).
Th1/Th17 immune response is enhanced in FoxP3
when compared to WT mice at the early stage of
infection (1 month p.i.)
To further explore the effect of FoxP3 on the immune
response during E. multilocularis infection, firstly,
Th-related cytokines were comparatively assessed in
AE-DEREG DTþ mice, in AE-WT mice, and in their
respective non-infected controls. Flow cytometry revealed
that T helper (Th) cells from AE-DEREG DTþ mice were
oriented toward a Th1 and Th17 pathway in PECs of mice
at early stage of infection (1 month p.i.). Respective flow
cytometric analyses showed that there was no difference
between spleen cells from AE-DEREG DTþ and
AE-DEREG DT- regarding expression of IFN-gþ and
IL-17Aþ within CD4þ T cells (Fig. 5A–D). Subsequently,
we assessed the same parameters but upon in vitro
cultivation and stimulation with ConA. We found that
expression of IFN-gþ and IL-17Aþ within CD4þ T cells
was significantly higher in spleen cells from AE-DEREG
DTþ at 1-month p.i., 48 h after exposure to ConA, when
compared to AE-DEREG DT- mice (Fig. 5E–H).
Figure 3. CD80 and CD86 expression levels in both CD11bþ and CD11cþ APCs, in both AE-DEREG DT- and AE-DEREG DTþ mice at 1 month post-
infection. (A) Frequency of CD80 and CD86 within CD11bþ APCs in peritoneal and spleen cells from AE-DEREG DT- and AE-DEREG DTþmice 1 month
post infection. (B) Representative images of CD86þ cells within CD11bþ cells in PECs frombothAE-DEREGDT- andAE-DEREGDTþmice at 1month post-
infection, non-infected mice as Control mice. (C) Frequency of CD80 and CD86 within CD11cþ APCs in peritoneal and spleen cells from AE-DEREG DT-
and AE-DEREG DTþmice 1 month post infection. (D) Representative images of CD86þ cells within CD11cþ APCs in PECs from both AE-DEREG DT- and
AE-DEREG DTþ mice at 1 month post-infection, non-infected mice as Control mice. DT application with 110 ng/injection/mouse started 1 day before
infection and was maintained for 4 months (three times/week). Data represent mean SD of three independent experiments of a total of 8–10 mice in
each group (4–5 mice per group in each independent experiment). Comparison between groups was performed using a one-way ANOVA with
Bonferroni's multiple comparison post-test for statistical analysis. p< 0.01. “DEREG DT-,” foxp3 inducible knock-downmice (DEREGmice) without DT
application; “DEREG DTþ ”, DEREGmice with DT application; “AE- DEREG DT-,” E. multilocularis-infected DEREG without DT application; “AE- DEREG
DTþ,” E. multilocularis-infected DEREG mice with DT application. “Control,” non-infected mice; “1m,” 1-month p.i.; “4m,” 4 months p.i.. “PEC,”
peritoneal exudate cells; “Spleen,” spleen cells.
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FoxP3 as a potential target for AE immunotherapy?
To explore whether FoxP3 could be tackled as a putative
target of immunotherapy against chronic E. multilocularis
infection, female-10-week-old DEREG mice were intra-
peritoneally infected with E. multilocularis, and subse-
quently treated with DT for 3 months after the infection
was established, that is, at 6 weeks p.i.. DT-Treated mice
(AE-DEREG DTþ) were compared to non-treated
mice (AE-DEREG DT-). We found that AE-DEREG
DTþ mice had no parasite growing at all when compared
to AE-DEREG DT- mice (0.00 0.00 vs. 15.95 2.61 g,
p< 0.001 (Fig. 6A), and this effect was associated with a
stronger Th1/Th17 response, and a lower IL-10 expression
level (Fig. 6B–D). In the AE-DEREG DTþ mice, where no
metacestode mass could be recovered post-mortem, the
initial infection efficacy was confirmed by appropriate
seropositivity upon Em2- and Em18-ELISA [9]. To assess a
potential non-Treg related effect of DT application on the
parasite growth in WT mice, we carried out the following
experiment in parallel: DT (110 ng/mouse three times/
week) was administered for a period of 3 months in
wild-type mice, beginning 6 weeks after E. multilocularis
infection. There was no difference in parasite load between
3-months-DT-treated and non-treated normal AE-WT
mice (Fig. 6A).
Figure 4. CD80 andCD86 expression levels in both CD11bþ andCD11cþAPCs, in response to ConA in both AE-DEREGDT- andAE-DEREGDTþmice at
1 month post-infection. (A) Frequency of CD80 and CD86 within CD11bþ APCs in spleen cells from AE-DEREG DT- and AE-DEREG DTþmice 1 month
post infection, co-cultured with 2mg/mL ConA. (B) Representative images of CD86þ cells within CD11bþ APCs in spleen cells from both AE-DEREG DT-
and AE-DEREG DTþ mice at 1 month post-infection (non-infected mice as Control mice), co-cultured with 2mg/mL ConA. (C) Frequency of CD80 and
CD86 within CD11cþ APCs in spleen cells from AE-DEREG DT- and AE-DEREG DTþ mice 1 month post infection, co-cultured with 2mg/mL ConA. (D)
Representative images of CD86þ cells within CD11cþ APCs in spleen cells from both AE-DEREG DT- and AE-DEREG DTþmice at 1 month post-infection
(non-infected mice as Control mice), co-cultured with 2mg/mL ConA. The same cell reactions performed without ConA were used as non-stimulated
controls. DT applicationwith 110 ng/injection/mouse started 1 day before infection andwasmaintained for 4months (three times/week). Data represent
mean SD of three independent experiments of a total of 8–10 mice in each group (4–5mice per group in each independent experiment). Comparison
between groups was performed using a one-way ANOVA with Bonferroni's multiple comparison post-test for statistical analysis. p< 0.01. “DEREG
DT-,” foxp3 inducible knock-down mice (DEREG mice) without DT application; “DEREG DTþ,” DEREG mice with DT application; “AE- DEREG DT-,”
E.multilocularis-infected DEREGwithout DT application; “AE- DEREGDTþ,” E.multilocularis-infected DEREGmicewith DT application. “Control,” non-
infected mice; “1m,” 1-month p.i.; “4m,” 4 months p.i.
Alveolar echinococcosis in the DEREG mouse J. Wang et al.
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Discussion
Chronic infection with E. multilocularis is characterized by a
marked immune tolerance status, which mainly includes a
down-regulation of periparasitic effector mechanisms; this
down-regulation of host immune response develops
progressively and reaches its maximum at the late stage of
infection/disease, both in human patients [10] and in
experimentally infected mice [11]. In the present study, we
identified FoxP3-expressing Tregs as an important immu-
nological factor promoting E. multilocularis proliferative
activity in mice. We showed that FoxP3-expressing Tregs (i)
contributed to suppressing Th1- and Th17-type immune
responses and (ii) down-regulated APC co-stimulatory
activities. Furthermore, we showed that down-regulation of
FoxP3-expression had the potential to be exploited for the
development of an immunotherapeutic strategy to reinforce
the control of larval E. multilocularis-infection by interfering
Figure 5. Th1/Th17 cell related cytokine expression in both AE-DEREG DT- and AE-DEREG DTþ mice at 1 month post-infection, and in response to
ConA. (A) Frequency of IFN-gþwithin CD4þ T cells in peritoneal and spleen cells fromAE-DEREGDT- andAE-DEREGDTþmice at 1month post infection,
non-infected mice as control mice. (B) Representative images of IFN-gþ cells within CD4þ T cells in PECs from both AE-DEREG DT- and AE-DEREG DTþ
mice at 1 month post-infection, non-infected mice as control mice. (C) Frequency of IL-17Aþ within CD4þ T cells in peritoneal and spleen cells from
AE-DEREG DT- and AE-DEREG DTþmice at 1month post infection, non-infectedmice as control mice. (D) Representative images of IL-17Aþ cells within
CD4þ T cells in PECs from both AE-DEREG DT- and AE-DEREG DTþmice at 1 month post-infection, non-infected mice as control mice. (E) Frequency of
IFN-gþwithin CD4þ T cells in peritoneal and spleen cells from AE-DEREG DT- and AE-DEREG DTþmice (non-infected mice as Control mice), co-cultured
with 2mg/mL ConA. (F) Representative images of IFN-gþ cells within CD4þ T cells in spleen cells from both AE-DEREG DT- and AE-DEREG DTþmice at
1 month post-infection (non-infected mice as Control mice), co-cultured with 2mg/mL ConA. (G) Frequency of IL-17Aþwithin CD4þ T cells in peritoneal
and spleen cells fromAE-DEREG DT- and AE-DEREG DTþmice (non-infected mice as Control mice), co-cultured with 2mg/mL ConA. (H) Representative
images of IL-17Aþ cells within CD4þ T cells in spleen cells from both AE-DEREG DT- and AE-DEREG DTþmice at 1 month post-infection (non-infected
mice as Control mice), co-cultured with 2mg/mL ConA. The same cell reactions performed without ConA were used as non-stimulated controls. DT
application with 110ng/injection/mouse started 1 day before infection and was maintained for 4 months (three times/week). Data represent mean SD
of three independent experiments of a total of 8–10 mice in each group (4–5 mice per group in each independent experiment). Comparison between
groups was performed using a one-way ANOVA with Bonferroni's multiple comparison post-test for statistical analysis. p< 0.0125. “DEREG DT-,”
foxp3 inducible knock-down mice (DEREG mice) without DT application; “DEREG DTþ,” DEREG mice with DT application; “AE- DEREG DT-,”
E.multilocularis-infected DEREGwithout DT application; “AE- DEREGDTþ,” E.multilocularis-infected DEREGmicewith DT application. “Control,” non-
infected mice; “1m,” 1-month p.i.; “4m,” 4 months p.i.. “PEC,” peritoneal exudate cells; “Spleen,” spleen cells.
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with the immunoregulatory pathways promoted by the
parasite in its host.
Our earlier studies had shown that CD4þCD25þ Tregs
were up-regulated in PECs from wild-type E. multilocularis-
infected mice [8] when compared to non-infected litter-
mates. Since Tregs appeared as one of the key immune
subsets to mediate the anergic immune status observed in
chronically infected mice, our present objective was to study
the role of FoxP3 Tregs in the co-modulation of the outcome
of E. multilocularis infection. Infecting DEREG mice with
E. multilocularis metacestode offered us a unique tool to
compare E. multilocularis hosts with and without depletion
of inducible FoxP3. This allowed us to demonstrate that
metacestode growth in AE-DEREG mice after depletion of
inducible FoxP3 Tregs yielded a significantly lower parasite
load not only when DTwas administered preventively before
E. multilocularis infection, but also when DT was adminis-
tered therapeutically when the infection was already
established. The latter observation is really unique if we
consider all attempts to modulate the immune response
reported previously [12], since it resulted in a complete
disappearance of liver lesions in infected DEREG mice
treated by DT after 6 weeks of infection. The effect on
metacestode growth was actually related to FoxP3þTreg
depletion since DT added to metacestode culture did not kill
the parasite in vitro, and wild-type mice treated by DT did
not exhibit any changes in parasite load.We were also able to
show that prevention and arrest of E. multilocularis growth
in DT-treated DEREG mice was associated with down-
regulation of T cell function, of T-cell co-stimulation, and of
dendritic cell (DC)maturation. Influence of regulatory T cell
depletion on the outcome of infection has been shown in
several models. Littwitz-Salomon et al. [13] showed a strong
increase of NK cell maturation, activation and effector
functions in Treg-depleted mice, and activated regulatory T
cells suppressed effector NK cell responses by an
IL-2-mediated mechanism during an acute retroviral
infection. Another study showed a significantly increased
Figure 6. Effects of FoxP3 as a post-infection treatment target, assessed upon parasite load in E. multilocularis infectedmice, and related T cell cytokine
expression measured by qRT-PCR. (A) Parasite load in AE-DEREG DT- and AE-DEREG DTþmice assessed by wet weight measurement at 4 months post-
infection. DT application with 110 ng/mouse (three times/week) started 6 weeks post infection and was maintained until 4 months. (B) Il-10 gene
expression level in peritoneal and spleen cells from AE-DEREG DT- and AE-DEREG DTþmice at 4 months post infection. (C) Ifn-g gene expression level in
peritoneal and spleen cells from AE-DEREG DT- and AE-DEREG DTþmice at 4 months post infection. (D) Il-17a gene expression level in peritoneal and
spleen cells from AE-DEREG DT- and AE-DEREG DTþmice at 4 months post infection. Data represent mean SD of two independent experiments of a
total of 8–10 mice in each group (4–5 mice per group in each independent experiment). Comparison between groups was performed using a one-way
ANOVAwith Bonferroni's multiple comparison post-test for statistical analysis. p< 0.017. “WT,”wild type; “DEREGDT-,” foxp3 inducible knock-down
mice (DEREG mice) without DT application; “DEREG DTþ,” DEREG mice with DT application; “AE-WT,” E. multilocularis-infected wild type mice; “
AE-DEREG DTþ,” E. multilocularis-infected DEREG mice with DT application. “Control,” non-infected mice; “1m,” 1 month p.i.; “4m,” 4 months p.i..
AU: arbitrary units.
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IL-6 level and a trend toward higher levels of TNF-a in
Treg-depleted mice during sepsis, which supported the
hypothesis that the hyper-inflammatory response during the
early phase of sepsis was intensified in mice lacking Treg
cells. Regarding parasitic infections, Treg cell depletion was
shown to augment a vaccine-induced T effector cell response
against the liver-stage of malaria even though it failed to
increase memory [14]. With regard to malignant tumors,
that share many immunological characteristics with para-
sites, Klages et al. [15] showed that Foxp3þ Treg depletion at
an intermediate time point resulted in an efficient regression
of melanoma tumor growth, and very efficiently controlled
the homeostasis of CD8þ T cells especially within the tumor
site. Furthermore, combining selective Foxp3þ Treg deple-
tion with vaccination improved the regression of established
tumors [15]. Taken together, our results confirm those
obtained with other models of infection or cancer associated
with immune evasion mechanisms and support the
hypothesis that the parasite’s strategy to increase its survival
and growth potential focuses on the involvement of
FoxP3-expressing Tregs, which contributes to the develop-
ment of a tolerance immune status in chronically infected
mice. Several studies in experimental mice and in patients
with AE suggested that in chronic infection effector
mechanisms were at least partially inhibited despite the
presence of potentially cytotoxic cells [3, 12, 16]. In the
present study, we showed that depletion of Foxp3þ-Tregs in
DEREG-mice was accompanied by a higher costimulatory
activity in both CD11bþ and CD11cþ APCs and by a
stronger Th1/Th17 immune response leading to an
improved control of E. multilocularis infection. Thus in
normal experimental hosts, Foxp3þ-Tregs, specifically
induced by secretory/excretory products of the metacestode,
as suggested by our in vitro experiments, might prevent APC
activation, limit the signal strength to T cell priming, and
permanently decrease Th1/Th17 effector response while
enhancing Th2-type cytokines, a hallmark of the immune
profile of AE [3, 12].
One striking observation was the lack of difference in
resistance between E. multilocularis-infected DEREG mice
thatwereDT-treated for only 1month versus those treated for
4 months; both groups exhibited similarly reduced parasite
burden. In a recently published paper, we showed that Foxp3
could not be kept knocked-down for a longer period of DT
administration due to subsequent antibody formation by
treated animals and DT-neutralization via DT-specific anti-
bodies [17]. To explain the mechanism that ensures that the
Treg niche is rapidly refilled following depletion, Nystr€om
et al. [18] suggested that these Treg cells could be (i) the
product of peripheral conversion of activated conventional
cells to peripherally induce Treg (pTreg) cells or (ii)
homeostatic proliferation of existing thymus-derived Treg
(tTreg) cells. A separate study found that homeostatic
expansion of Treg cells (through proliferation and reduced
apoptosis) could completely restore the compartment
following 50% Treg-cell depletion, with no evidence of
conversion of conventional T cells observed [19]. An
additional parameter contributing to this phenomenon
may be by neutralizing-.antibodies that may affect
DT-function concerning inhibition of Foxp3-expression [17].
How FoxP3þTregs causatively influence and/or modulate
the outcome of experimental AE is still unclear, although
various molecular and cellular mechanisms have been
proposed to explain how Tregs may basically suppress
immune responses. These include cell-to-cell contact-
dependent suppression, cytotoxicity, and immunoregula-
tory cytokine secretion such as IL-10 and TGF-b [20], two
immunoregulatory cytokines widely expressed in the liver
lesions and present in the plasma of patients with AE
[4, 7, 12]. However, the importance of these cytokines
remains controversial, as several studies have demonstrated
that antibodies directed against IL-10 and TGF-b failed to
block Treg suppressive function, and Tregs from
TGF-b–deficient mice retained normal suppressive activity
in vitro [20]. In addition, the ambiguous role of TGF-b,
which is both a strong inducer of immune tolerance and an
activator of the pro-inflammatory IL-17 cytokine system,
remains puzzling [21, 22]. However, previous studies
strongly suggest that both regulatory cytokines are impor-
tant actors in Echinococcus spp. immune evasion [5, 7, 10].
Specific influence of parasitic products on IL-23 could be a
key-step in the modulation of IL-17 promotion or
suppression and of Th17/Treg balance [5], and should be
studied more in depth in future work.
Our findings on the role of Foxp3þ Tregs in
E. multilocularis infection now open the door for more
applied approaches. Understanding the mechanism by
which FoxP3 expression regulates the immune process in
AE could help find new immunotherapeutic targets, since
the metacestode disappearance we observed by depleting
FoxP3 Treg cells in hosts with fully established metacestode
was never equaled with other types of immune manipula-
tion; up to now, only pre-infection administration of IL-12
was able to effectively suppress AE occurrence in the mouse
model; as this was not applicable to humans, it was never
tested as a therapeutic agent [23]. However, directly
targeting FoxP3 and acting on all FoxP3-expressing Treg
cells without discrimination might be harmful, especially by
promoting allergy and auto-immunity. Treg cells play a role
in the development of the immune response after birth and
have been associated with environmental conditions which
promote protection against allergy; however, this positive
influence of Tregs to prevent allergy is operating in early life,
and is far less crucial later on [24]. Contribution of Tregs to
alleviation of experimental allergic asthma has also been
shown after specific immunotherapy [25]; however, a direct
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contribution of Tregs to the development of IgE-dependent
allergy in adults is more controversial. Treg cells play a
dominant role in the suppression of autoimmune reactions/
diseases. In themouse, a lack of CD4þ FoxP3þTregs resulted
in increased autoimmunity, and adoptive transfer of Treg
prevented and reversed autoimmunity [26]. In humans, lack
of functional Tregs also leads to autoimmunity, as is seen in
individuals who have immune-dysregulative polyendocrin-
opathy and enteropathy X-linked (IPEX) syndrome due to
mutations in FoxP3. These individuals develop aggressive
autoimmunity including insulin-dependent diabetes, thy-
roiditis and eczema [27, 28]. Depletion of Tregs also
increased disease severity of actively induced and adoptively
transferred murine autoimmune neuritis [29]. However,
Savarin et al. [30] also showed that residual Foxp3þ Tregs
detected 1week after DT treatment might be sufficient to
control central nervous system (CNS) inflammation. The
minor Foxp3þ Treg population detected at day 28 p.i.
presumably comprised rebound Tregs, as well as a small
proportion of DT-insensitive Foxp3þ cells detected in adult
DEREG mice [31]. While rebound Tregs are dysfunc-
tional [32], DT-resistant Foxp3þ Tregs have been shown to
protect against lethal autoimmunity and suffice to control
the self-reactive (SR) CD4þ T cells during chronic mouse
hepatitis virus infection [31]. Our observations made in
AE-DEREG mice DT-treated for only 1 month versus those
treated for 4 months might support an efficient action on
parasite growth using time-limited administration of anti-
Treg biological agents while avoiding auto-immune reac-
tions. All these issues should be studied very carefully before
any therapeutic application to humans, keeping inmind that
AE is a very severe tumor-like disease still without fully
effective anti-infective therapy [1].
Materials and Methods
Ethics statement
The animal study was performed in strict accordance with
the recommendations of the Swiss Guidelines for the Care
and Use of Laboratory Animals. The protocol was approved
by the governmental Commission for Animal Experimenta-
tion of the Canton of Bern (approvals no. BE103/11 and
BE112/14).
Experimental design, parasite sampling, and
histological examinations
Mice
DEREG (depletion of regulatory T cells) mice of the C57/
BL6-background and respective wild-type littermates, all
aged between 8 and 10 weeks, were used for intraperitoneal
infection with E. multilocularis as previously described [33].
Age-and-gender-matched littermates were used for mock-
infected control groups. In DEREG mice, a diphtheria toxin
(DT) receptor together with an enhanced green fluorescent
protein (eGFP) is expressed under the control of the FoxP3
promoter. Therefore, depletion of Treg cells can be achieved
by appropriate DT application [32]. As shown else-
where [34], in na€ve DEREG mice a subset of FoxP3þ Treg
cells lacking the DT receptor and GFP expression is not
affected by the treatment. All animals were bred and housed
under specific pathogen free (SPF) conditions according to
recommendations of the Federation of European Laboratory
Animal Science Association (FELASA), and additionally
monitored by daily inspection, including the assessment of
the appearance of health status, putative weight loss or gain
during the whole course of the experiment. All experiments
with animals were performed within a laminar flow safety
enclosure.
Parasite and experimental infection
E. multilocularis (H95) was isolated and maintained by
serial passages (vegetative transfer) in C57BL/6 mice as
previously described [35]. In order to prepare the infection
material for mice, metacestode tissue was obtained from
previously infected mice by aseptic removal from the
peritoneal cavity. After grinding the tissue through a sterile
50mm sieve, approximately 100 freshly prepared vesicular
cysts were suspended in 100mL RPMI-1640 (Gibco, Basel,
Switzerland) and intraperitoneally (i.p.) injected. Each
experimental group included six animals unless otherwise
stated. Control mice (mock-infection) received 100mL of
RPMI-1640 only.
Treg cell depletion
DEREG-C57/BL6 mice (DEREG) and their WT littermate
(WT) controls were either used as infected animals or as
non-infected controls. All mice belonging to the Treg cell
depletion group (knockouts and WT control animals)
received 110 ng of DT i.p. (Calbiochem, Merck, Germany)
dissolved in 100ml PBS at 1 day before infection till (a)
1 month p.i. with a frequency of three applications/week, or
until (b) 4month p.i., with a frequency of three applications/
week. Successful depletion and rebound of Treg cells was
confirmed by flow cytometric analysis based on the detection
of the FoxP3eGFP signal in splenic leukocytes. Infected mice
were daily monitored for survival and morbidity.
Parasite tissue mass and quantification
Mice were sacrificed by CO2-euthanasia at 1 month (corre-
sponding to an early stage of chronic infection) and 4months
(corresponding to a middle/late¼ chronic stage of disease)
p.i.. Blood was collected by cardiac puncture, and serum
samples were stored at808C. Parasite tissues were dissected
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and, if present, fat and connective tissues were carefully
removed for subsequent determination of the parasite
mass.
Cell preparations
Peritoneal exudate cells (PEC) and spleen cells from na€ve
(control) and E. multilocularis-infected (AE) DEREG and
WT mice were collected by peritoneal rinsing, or grinding
separately with 5mL RPMI-1640. Cells were subsequently
washed twice and resuspended in RPMI-1640 (Gibco) for
cell staining or cell culture.Macrophages were removed from
each group of mice by plastic-adhesion after incubation of
PEC or spleen cell suspension in 15mL RPMI-1640þ 20%
FCS in a petri-dish for 2 h at 378C, in an atmosphere
containing 5% CO2. Subsequent to incubation, non-
adherent cells were separated from macrophage-enriched
adherent cells, and this new cell suspension was used for
FACS analyses.
Spleen cell stimulation assays
Spleen cells were cultured at a density of 2 106 cells/mL in
RPMI-1640 þ10%FCS, and stimulated with 2mg/mL ConA
for 48 h, orwith different concentrations ofVF for 96 h, aimed
at surface marker staining. The same cell reactions performed
without ConA orVFwere used as negative controls. The same
stimulation but in the presence of protein-transport inhibi-
tor-cocktail was used for cytokine staining.
Flow cytometry
Aliquots of 106 cells/100mL of staining buffer per well were
incubated each with 1mg of purified anti-CD16/CD32 for
20min in the dark, in order to block non-specific binding of
antibodies to the FcgIII and FcgII receptors. Subsequently,
these cells were separately stained with the following surface
markers for 15min with 1mg of primary antibodies: APC-
labeled anti-CD4, FITC-labeled anti-CD25, anti-CD80, anti-
CD86, anti-CD40, anti-MHCII; PE-labeled anti-CD11b,
anti-CD11c. All antibodies were from eBioscience (San
Diego, CA). For intracellular staining, PECs or spleen cells
were first incubated with Inside Fix (Miltenyi Biotec,
Bergisch Gladbach, Germany) for 20min at room tempera-
ture and subsequently stained with PE-labeled anti-IFN-g,
anti-IL-4, anti-IL-17A, anti-IL-10 and anti-Foxp3
(eBioscience, San Diego, CA) in Inside Perm (Miltenyi
Biotec, Bergisch Gladbach, Germany) for 15min in the dark.
Corresponding fluorochrome-labeled isotype control anti-
bodies were used for staining controls. Cells resuspended in
300mL of buffer (0.15M NaCl, 1mM NaH2PO4 H2O,
10mMNa2HPO4 2H2O and 3mMNaN3) were analyzed in a
flow cytometer (Becton Dickinson, Heidelberg, Germany)
using the corresponding CELL QUEST software.
Total RNA extraction and qRT-PCR
Total RNA was isolated from spleens using the Qiagen
RNeasy MiniKit according to the manufacturer’s instruc-
tions. The quality of the isolated RNA was determined
with a NanoDrop ND 1000 (NanoDrop Technologies,
Witec AG, Lucerne, Switzerland) and a Bioanalyzer 2100
(Agilent Technologies AG, Bassel, Switzerland). Only
samples with a 260-nm:280-nm ratio between 1.9 and
2.1 and a 28S:18S ratio within 1.5 to 2 were further
processed. cDNA was synthesized using the Omniscript
Reverse Transcription kit (Qiagen, Hilden, Germany).
SYBR-Green Mix-based qRT-PCR was carried out on a
Rotor-Gene 6000 qPCR detection system (Corbett) with
the FastStart Essential DNA Green Master (Roche, Basel,
Switzerland) following the manufacturer’s instructions.
PCR cycling was performed in triplicates in final volumes
of 20mL containing 2mL cDNA and 10 pM of each primer
(Cycle scheme: initial denaturation at 958C—15min,
45 cycles of 958C—15 s, 558C—30 s, and 728C—30 s).
Fluorescence was measured in every cycle, and a melting
curve was analyzed after the PCR by increasing the
temperature from 55 to 958C in 0.58C increments. The
primers used were described earlier [4], and mRNA levels
of different cytokines were quantified relative to the mRNA
level of housekeeping gene b-actin.
Statistical analyses
All data were analyzed by SPSS 17.0. The results are
presented as means SD. Normality of data was assessed by
D’Agostino & Pearson and Shapiro–Willk test. For normally
distributed groups pf data, One-way ANOVA followed by
Bonferroni’s post-test or un-paired two-tail Student’s t-test
were used to compare the differences between groups.
Significance was defined as p< 0.05 for all tests, except those
subsequently corrected by Bonferroni.
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Figure S1. Inhibition of FoxP3 expressionwith CD4T cells in
peritoneal cells from both AE-DEREG DT- and AE-DEREG
DTþ mice at 1 month and 4 months post-infection. (A)
Frequency of FoxP3þ within CD4þ T cells in PECs from AE-
DEREG DT- and AE-DEREG DTþ mice at 1 month and
4 months post-infection, non-infected mice as control mice,
DT applicationwith 110 ng/mouse (three times/week) started
1 day before infection and was maintained for 4 months. (B)
Representative images of FoxP3þwithinCD4þT cells in PECs
fromAE-DEREGDT- andAE-DEREGDTþmice at 1month
and 4 months post-infection, non-infected mice as control
mice. DT application with 110 ng/mouse (three times/week)
started 1 day before infection and was maintained for
4 months. (C) Frequency of FoxP3þ within CD4þ T cells in
PECs from AE-DEREG DT- and AE-DEREG DTþ mice at
1 month and 4 months post-infection, non-infected mice as
control mice. DT application with 110 ng/injection/mouse
(three times/week) started 1 day before infection and was
maintained for 1 month. (D) Representative images of
FoxP3þ within CD4þ T cells in PECs from AE-DEREG DT-
and AE-DEREG DTþ mice at 1 month and 4 months post-
infection, non-infected mice as control mice. DT application
with 110ng/injection/mouse (three times/week) started 1 day
before infection and was maintained for 1 month. Data
represent mean SD of three independent experiments of a
total of 8–10 mice in each group (4–5 mice per group in each
independent experiment). Comparison between groups was
performed using a one-way ANOVA with Bonferroni’s
multiple comparison post-test for statistical analysis.
p< 0.01. ‘‘DEREG DT-,’’ foxp3 inducible knock-down
mice (DEREG mice) without DT application; ‘‘DEREG
DTþ,’’ DEREG mice with DT application; ‘‘AE-DEREG
DT-,’’ E. multilocularis-infected DEREGwithout DT applica-
tion; ‘‘AE-DEREG DTþ,’’ E. multilocularis-infected DEREG
mice with DT application. ‘‘Control,’’ non-infected mice;
‘‘1m,’’ 1-month p.i.; ‘‘4m,’’ 4 months p.i.
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